Unknown

Dataset Information

0

Integration of pathologic characteristics, genetic risk and lifestyle exposure for colorectal cancer survival assessment.


ABSTRACT: The development of an effective survival prediction tool is key for reducing colorectal cancer mortality. Here, we apply a three-stage study to devise a polygenic prognostic score (PPS) for stratifying colorectal cancer overall survival. Leveraging two cohorts of 3703 patients, we first perform a genome-wide survival association analysis to develop eight candidate PPSs. Further using an independent cohort with 470 patients, we identify the 287 variants-derived PPS (i.e., PPS287) achieving an optimal prediction performance [hazard ratio (HR) per SD = 1.99, P = 1.76 × 10-8], accompanied by additional tests in two external cohorts, with HRs per SD of 1.90 (P = 3.21 × 10-14; 543 patients) and 1.80 (P = 1.11 × 10-9; 713 patients). Notably, the detrimental impact of pathologic characteristics and genetic risk could be attenuated by a healthy lifestyle, yielding a 7.62% improvement in the 5-year overall survival rate. Therefore, our findings demonstrate the integrated contribution of pathologic characteristics, germline variants, and lifestyle exposure to the prognosis of colorectal cancer patients.

SUBMITTER: Xin J 

PROVIDER: S-EPMC11002003 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Integration of pathologic characteristics, genetic risk and lifestyle exposure for colorectal cancer survival assessment.

Xin Junyi J   Gu Dongying D   Li Shuwei S   Qian Sangni S   Cheng Yifei Y   Shao Wei W   Ben Shuai S   Chen Silu S   Zhu Linjun L   Jin Mingjuan M   Chen Kun K   Hu Zhibin Z   Zhang Zhengdong Z   Du Mulong M   Shen Hongbing H   Wang Meilin M  

Nature communications 20240408 1


The development of an effective survival prediction tool is key for reducing colorectal cancer mortality. Here, we apply a three-stage study to devise a polygenic prognostic score (PPS) for stratifying colorectal cancer overall survival. Leveraging two cohorts of 3703 patients, we first perform a genome-wide survival association analysis to develop eight candidate PPSs. Further using an independent cohort with 470 patients, we identify the 287 variants-derived PPS (i.e., PPS<sub>287</sub>) achie  ...[more]

Similar Datasets

| S-EPMC6639208 | biostudies-literature
| S-EPMC9875451 | biostudies-literature
| S-EPMC3756543 | biostudies-literature
| S-EPMC6279591 | biostudies-literature
| S-EPMC3738138 | biostudies-other
| S-EPMC10417168 | biostudies-literature
| S-EPMC8781285 | biostudies-literature
| S-EPMC5800969 | biostudies-literature
| S-EPMC5985207 | biostudies-literature
| S-EPMC9865072 | biostudies-literature